IsoEnergy Closes $1.1 Million Private Placement of Flow-Through Shares and Extends Radio Option Agreement

IsoEnergy Closes $1.1 Million Private Placement of Flow-Through Shares and Extends Radio Option Agreement

Canada NewsWire

VANCOUVER, May 26, 2017 /CNW/ - IsoEnergy Ltd. (“IsoEnergy” or the “Company”) (TSXV: ISO) is pleased to announce that it has completed a non-brokered, private placement of 999,999 flow-through common shares at a price of $1.10 per share, raising aggregate gross proceeds of $1,099,998.90.

IsoEnergy will use the proceeds of the private placement to continue its exploration activities on its projects in the Athabasca Basin, Saskatchewan.  The securities issued pursuant to the offering are subject to a hold period of four months and one day from the closing date of the offering.

In connection with the offering, the Company paid a cash finder’s fee to EMD Financial Inc., equal to 6% of the gross proceeds raised from placees.

The Company has also granted 50,000 stock options on May 25, 2017 to a contract geologist having an exercise price of $1.00, a term of five (5) years, and vesting as to one third on the grant date and each of the second and third anniversary thereof.

Finally, the Company has entered into an agreement extending the date for the exercise by the Company of its exclusive option to acquire a 70% interest in the Radio property option to June 20, 2017.

About IsoEnergy

IsoEnergy is a well-funded uranium exploration and development company with a portfolio of prospective projects in the eastern Athabasca Basin in Saskatchewan, Canada and a historic inferred mineral resource at the Mountain Lake uranium deposit in Nunavut. IsoEnergy is led by a Board and Management team with a track record of success in uranium exploration, development and operations. The Company was founded and is supported by the team at its major shareholder, NexGen Energy Ltd.

Neither the TSX Venture Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. “Forward-looking information” includes, but is not limited to, statements with respect to the activities, events or developments that the Company expects or anticipates will or may occur in the future. Generally, but not always, forward-looking information and statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or the negative connotation thereof or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative connotation thereof.

Forward-looking information and statements are based on the then current expectations, beliefs, assumptions, estimates and forecasts about IsoEnergy’s business and the industry and markets in which it operates. Forward-looking information and statements are made based upon certain assumptions and other important factors that could cause the actual results, performances or achievements of IsoEnergy to be materially different from future results, performances or achievements expressed or implied by such information or statements. Such information and statements are based on numerous assumptions including, among others, the results of planned exploration activities are as anticipated, the price of uranium, the anticipated cost of planned exploration activities, that general business and economic conditions will not change in a material adverse manner, that financing will be available if and when needed on reasonable terms and that third party contractors, equipment, supplies and governmental and other approvals required to conduct IsoEnergy’s planned exploration activities will be available on reasonable terms and in a timely manner.

Forward-looking information and statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of IsoEnergy to be materially different from any future results, performance or achievements expressed or implied by such forward- looking statements. Such factors include, among others, risks related to the negative operating cash flow and dependence on third party financing; the uncertainty of additional financing; potential forfeiture of the Radio Option Agreement; the limited operating history of IsoEnergy; the lack of known mineral resources or reserves; the influence of a large shareholder; alternate sources of energy and uranium prices; aboriginal title and consultation issues; risks related to exploration activities generally; reliance upon key management and other personnel; title to properties; uninsurable risks; conflicts of interest; permits and licenses; environmental and other regulatory requirements; political regulatory risks; competition; and the volatility of share price, all as more particularly described under “Risk Factors” in the Company’s Listing Application available at www.sedar.com.

Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information or implied by forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company undertakes no obligation to update or reissue forward-looking information as a result of new information or events except as required by applicable securities laws.

SOURCE IsoEnergy Ltd.

View original content: http://www.newswire.ca/en/releases/archive/May2017/26/c7506.html

Middlefield Healthcare & Life Sciences Dividend Fund Files Initial Public Offering

Middlefield Healthcare & Life Sciences Dividend Fund Files Initial Public Offering

Canada NewsWire

CALGARY, May 26, 2017 /CNW/ – Middlefield Group, on behalf of Middlefield Healthcare & Life Sciences Dividend Fund (the “Fund”), is pleased to announce that it has filed a preliminary prospectus in relation to an initial public offering of units at a price of $10.00 per unit.

The Fund’s investment objectives are to provide holders of units with:

(i) stable monthly cash distributions, and

(ii) enhanced long-term total return through capital appreciation of the Fund’s investment portfolio.

The Fund’s investment strategy will focus primarily on investing in dividend-paying securities of issuers operating in, or that derive a significant portion of their revenue or earnings from, products or services related to the healthcare, life sciences and related industries.

The initial target distribution yield for the Fund is 5% per annum based on the original subscription price (or $0.04167 per unit per month or $0.50 per unit per annum).

Middlefield Capital Corporation, the advisor, will provide investment management advice to the Fund. SSR LLC, an investment research firm based in Stamford, Connecticut, will act as an industry advisor to Middlefield and in such capacity will provide ongoing analysis regarding the global healthcare and life sciences sector.

Prospective purchasers investing in Middlefield Healthcare & Life Sciences Dividend Fund have the option of paying for units in cash or by exchanging securities of issuers listed in the preliminary prospectus. Prospective purchasers under the exchange option are required to deposit their exchange eligible securities prior to 5:00 p.m. (Toronto time) on June 22, 2017, in the manner described in the preliminary prospectus.

The syndicate of agents is being co-led by CIBC and RBC Capital Markets, and includes BMO Capital Markets, Scotiabank, TD Securities Inc., Canaccord Genuity Corp., GMP Securities L.P., National Bank Financial Inc., Raymond James Ltd., Manulife Securities Incorporated, Echelon Wealth Partners Inc., Mackie Research Capital Corporation and Middlefield Capital Corporation.


A preliminary prospectus containing important information relating to these securities has been filed with securities commissions or similar authorities in each of the provinces of Canada. The preliminary prospectus is still subject to completion or amendment. Copies of the preliminary prospectus may be obtained from any of the agents named above using the contact information for such agent. There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued.

SOURCE Middlefield Healthcare & Life Sciences Dividend Fund

View original content: http://www.newswire.ca/en/releases/archive/May2017/26/c1878.html

Emergent Capital, Inc. Announces Supplement No. 1 to Exchange Offer

Emergent Capital, Inc. Announces Supplement No. 1 to Exchange Offer

PR Newswire

BOCA RATON, Fla., May 26, 2017 /PRNewswire/ — Emergent Capital, Inc. (OTCQB: EMGC) (“Emergent” or the “Issuer”) today announced that it has supplemented the terms of its previously announced offer to exchange (the “Exchange Offer”) any and all of its outstanding $74,220,450 aggregate principal amount of 8.50% Senior Unsecured Convertible Notes due 2019 (the “Old Notes”) for $74,220,450 aggregate principal amount of a new series of 5.00% Senior Unsecured Convertible Notes due 2023 (the “New Unsecured Notes”) together with a right to subscribe (the “Rights Offering”) for 500 shares of Emergent’s $0.01 par value common stock at $0.20 per share for each $1,000 principal amount of Old Notes tendered up to an aggregate of 40,000,000 shares, and its previously announced solicitation of consents (the “Consent Solicitation”) from the holders of the Old Notes to eliminate substantially all restrictive covenants contained in the Old Notes Indenture and the Old Notes (the “Proposed Amendments”).  In addition to its supplement number 1 to its offer to exchange, Emergent has also amended and restated its consent and letter of transmittal.  The supplement number 1 and the amended and restated consent and letter of transmittal provide additional disclosure about exchange procedures for the Exchange Offer and subscription procedures for the Rights Offering.  The supplement number 1 also provides additional disclosure about certain ownership interests in the Old Notes, withdrawal rights if Emergent has failed to accept validly tendered Old Notes after the 40th business day after the commencement of the Exchange Offer, conditions of the Exchange Offer, Consent Solicitation and Rights Offering, the execution and delivery of a bridge note, and certain supplemental summary and pro forma financial information among other modifications to the Exchange Offer.  

As of 5:00 p.m., New York City time, on May 25, 2017, according to US Bank, the Information Agent and Exchange Agent for the Exchange Offer, $1,508,450, or 2.03%, of the aggregate principal amount of the Old Notes had been validly tendered and not withdrawn in the Exchange Offer.

The Expiration Date of the Exchange Offer, Consent Solicitation and Rights Offering, as amended by Emergent, is June 12, 2017. 

General

This announcement shall not constitute an offer to purchase or a solicitation of an offer to sell any securities. The complete terms and conditions of the Exchange Offer are set forth in the offer to exchange dated April 18, 2017, the related consent and letter of transmittal that have been sent to eligible holders of the Old Notes, the amended and restated consent and letter of transmittal, and the supplement number 1 to the offer to exchange. The Exchange Offer, Rights Offering and Consent Solicitation for the Old Notes is being made only through, and subject to the terms and conditions set forth in, the Exchange Offer documents and related materials.

The New Unsecured Notes will not initially be registered under the Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States absent an effective registration statement or an applicable exemption from registration requirements or in a transaction that is not subject to the registration requirements of the Securities Act or any state securities laws.

US Bank is acting as the Information Agent and Exchange Agent for the Exchange Offer. Questions concerning tender procedures and requests for additional copies of the related consents and letters of transmittal may be directed to US Bank at (651) 466-5622 (for brokers and banks) or (800) 934-6802 (for all others).

Neither Emergent’s board of directors nor any other person makes any recommendation as to whether holders of Old Notes should exchange such notes, and no one has been authorized to make such a recommendation. Eligible holders of Old Notes must make their own decisions as to whether to exchange their Old Notes, and if they decide to do so, the principal amount of the Old Notes to exchange. Eligible holders of Old Notes should read carefully the Exchange Offer documents described above and related materials before any decision is made with respect to the Exchange Offer, Rights Offering and consent solicitation.

About Emergent Capital, Inc.

Emergent Capital, Inc. (OTCQB: EMGC) is a specialty finance company that invests in life settlements.  More information about Emergent can be found at www.emergentcapital.com.  

Safe Harbor Statement

This press release may contain certain “forward-looking statements” relating to the business of Emergent Capital, Inc. and its subsidiary companies. All statements, other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions, and involve known and unknown risks and uncertainties. Although Emergent believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release.  These statements include, but may not be limited to, those relating to the proposed exchange offer, the Proposed Amendments, and the transactions expected to be engaged in in connection with the proposed exchange offer.  In addition to the risks and uncertainties noted in this release, there are certain factors that could cause actual results to differ materially from those anticipated by some of the statements made. These include (1) risks associated with the transactions contemplated by the exchange offer, including but not limited to risks related to the failure to close the transactions contemplated by the exchange offer, including due to the failure to receive the minimum requisite tender, (2) the ability to successfully complete the other transactions related to our recapitalization efforts, (3) loss of key management and other personnel, (4) risks associated with our debt leverage and operating covenants under our debt instruments, (5) changes in economic conditions in the United States and abroad, and (6) other risks, uncertainties and other factors described in Emergent’s quarterly reports on Form 10-Q and annual reports on Form 10-K and in Emergent’s other filings with the U.S. Securities and Exchange Commission (SEC) or in materials incorporated therein by reference. Other than as required under the securities laws, Emergent does not assume a duty to update these forward-looking statements to reflect subsequent events or circumstances or actual outcomes.  Actual results could vary materially depending on such risks and uncertainties that may affect Emergent and its business.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/emergent-capital-inc-announces-supplement-no-1-to-exchange-offer-300464822.html

SOURCE Emergent Capital, Inc.